STC2 regulates the proliferation, migration and glycolysis of glioma cells through modulating ITGB2

被引:0
作者
Wei, Zefeng [1 ]
Ge, Dengfeng [2 ]
Bu, Jie [3 ]
Wang, Xuenan [1 ]
Zhong, Tao [3 ]
Gongye, Xiaoxiao [3 ]
Zhang, Bin [2 ]
Yan, Feng [4 ]
He, Chunyan [3 ]
Guo, Runhan [3 ]
Li, Jiayi [3 ]
Jin, Zhenzhen [1 ]
机构
[1] Jining Med Univ, Ctr Reprod Med, Affiliated Hosp, Jining 272029, Peoples R China
[2] Nanjing Univ Chinese Med, Jiangsu Prov Hosp Chinese Med, Dept Cardiothorac Surg, Nanjing 210023, Peoples R China
[3] Jining Med Univ, Jining 272067, Peoples R China
[4] Peoples Hosp Qufu, Jining 273100, Peoples R China
关键词
Glioma; Glycolysis; ITGB2; STC2; EPITHELIAL-MESENCHYMAL TRANSITION; GENE SIGNATURE; PROMOTES; CANCER; STANNIOCALCIN-2; OVEREXPRESSION; CD18;
D O I
10.1007/s11011-025-01571-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Glioma is a common and aggressive primary malignant brain tumor. However, the progression mechanism of glioma has not been well revealed. In this study, we intend to detect the function and related mechanism of STC2 in glioma. Gene Expression Profiling Interactive Analysis database was used to detect STC2 and ITGB2 expression in glioma samples, as well as the relationship between STC2 and other genes. The relationship between STC2 and ITGB2 was confirmed by co-immunoprecipitation assay. The biology function of glioma cells was determined by cell counting kit-8, colony formation, transwell, ELISA and western blot assays. We discovered that STC2 was highly expressed in glioma samples and cell lines. Knocked down of STC2 inhibited cell proliferation, invasion, migration and glycolysis. Further analysis demonstrated the interaction between ITGB2 and STC2 as well as its involvement in STC2-regulated proliferation, invasion, migration and glycolysis. In summary, our data afforded novel insights into understanding the regulatory mechanism of STC2 and suggested that the STC2/ITGB2 axis might be a potential therapeutic target for glioma.
引用
收藏
页数:10
相关论文
共 35 条
[21]   Stanniocalcin 2 (STC2): a universal tumour biomarker and a potential therapeutical target [J].
Qie, Shuo ;
Sang, Nianli .
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2022, 41 (01)
[22]   The emerging role of microRNA-based therapeutics in the treatment of preeclampsia [J].
Selvakumar, Sushmaa Chandralekha ;
Preethi, K. Auxzilia ;
Ross, Kehinde ;
Sekar, Durairaj .
PLACENTA, 2024, 158 :38-47
[23]   MicroRNA-510-3p regulated vascular dysfunction in Preeclampsia by targeting Vascular Endothelial Growth Factor A (VEGFA) and its signaling axis [J].
Selvakumar, Sushmaa Chandralekha ;
Preethi, Auxzilia K. ;
Sekar, Durairaj .
PLACENTA, 2024, 153 :31-52
[24]   Multifunctional nanocarriers for delivering siRNA and miRNA in glioblastoma therapy: advances in nanobiotechnology-based cancer therapy [J].
Shetty, Karishma ;
Yasaswi, Soma ;
Dutt, Shilpee ;
Yadav, Khushwant S. .
3 BIOTECH, 2022, 12 (11)
[25]   Stanniocalcin 2 overexpression in castration-resistant prostate cancer and aggressive prostate cancer [J].
Tamura, Kenji ;
Furihata, Mutsuo ;
Chung, Su-Yong ;
Uemura, Motohide ;
Yoshioka, Hiroki ;
Iiyama, Tatsuo ;
Ashida, Shingo ;
Nasu, Yasutomo ;
Fujioka, Tomoaki ;
Shuin, Taro ;
Nakamura, Yusuke ;
Nakagawa, Hidewaki .
CANCER SCIENCE, 2009, 100 (05) :914-919
[26]   The leucocyte β2 (CD18) integrins: the structure, functional regulation and signalling properties [J].
Tan, Suet-Mien .
BIOSCIENCE REPORTS, 2012, 32 (03) :241-269
[27]   Stanniocalcin 2 promotes invasion and is associated with metastatic stages in neuroblastoma [J].
Volland, Sonja ;
Kugler, Wilfried ;
Schweigerer, Lothar ;
Wilting, Joerg ;
Becker, Juergen .
INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (09) :2049-2057
[28]   STC2 overexpression mediated by HMGA2 is a biomarker for aggressiveness of high-grade serous ovarian cancer [J].
Wu, Jingjing ;
Lai, Maode ;
Shao, Changshun ;
Wang, Jian ;
Wei, Jian-Jun .
ONCOLOGY REPORTS, 2015, 34 (03) :1494-1502
[29]   ITGB2 as a prognostic indicator and a predictive marker for immunotherapy in gliomas [J].
Xu, Houshi ;
Zhang, Anke ;
Han, Xiaying ;
Li, Yanning ;
Zhang, Zeyu ;
Song, Liying ;
Wang, Wei ;
Lou, Meiqing .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (03) :645-660
[30]   Immunotherapy for glioma: Current management and future application [J].
Xu, Shengchao ;
Tang, Lu ;
Li, Xizhe ;
Fan, Fan ;
Liu, Zhixiong .
CANCER LETTERS, 2020, 476 :1-12